GEN1503

Diabetes mellitus (type 1 & type 2)

PreclinicalActive

Key Facts

Indication

Diabetes mellitus (type 1 & type 2)

Phase

Preclinical

Status

Active

Company

Developing low‑cost insulin biosimilars to expand global diabetes care.

Drug	Company	Phase	Status
GEN1501	GeneSys	Preclinical	Active
GEN1502	GeneSys	Preclinical	Active
GEN1504	GeneSys	Preclinical	Active